《多病多药病人管理指南》要点解读及拓展

2023-02-10 华中科技大学同济医学院附属同济医院 循证护理 发表于安徽省

解读意大利多病多药病人管理指南要点,探讨老年多病多重用药国际现状,旨在借鉴国外经验,建立更适合我国国情的老年多病多重用药的管理,以提高我国老年人的生存质量,并为我国学者研究提供方向及循证依据。

中文标题:

《多病多药病人管理指南》要点解读及拓展

发布日期:

2023-02-10

简要介绍:

解读意大利多病多药病人管理指南要点,探讨老年多病多重用药国际现状,旨在借鉴国外经验,建立更适合我国国情的老年多病多重用药的管理,以提高我国老年人的生存质量,并为我国学者研究提供方向及循证依据。

相关资料下载:
[AttachmentFileName(sort=1, fileName=《多病多药病人管理指南》要点解读及拓展.pdf)] GetToolGuiderByIdResponse(projectId=1, id=e30a61c0029e637d, title=《多病多药病人管理指南》要点解读及拓展, enTitle=, guiderFrom=循证护理, authorId=0, author=, summary=解读意大利多病多药病人管理指南要点,探讨老年多病多重用药国际现状,旨在借鉴国外经验,建立更适合我国国情的老年多病多重用药的管理,以提高我国老年人的生存质量,并为我国学者研究提供方向及循证依据。, cover=https://img.medsci.cn/Random/doctor-is-working-at-the-hospital-PAJM2K5.jpg, journalId=0, articlesId=null, associationId=2725, associationName=华中科技大学同济医学院附属同济医院, associationIntro=华中科技大学同济医学院附属同济医院, copyright=0, guiderPublishedTime=Fri Feb 10 00:00:00 CST 2023, originalUrl=, linkOutUrl=, content=<p>解读意大利多病多药病人管理指南要点,探讨老年多病多重用药国际现状,旨在借鉴国外经验,建立更适合我国国情的老年多病多重用药的管理,以提高我国老年人的生存质量,并为我国学者研究提供方向及循证依据。</p>, tagList=[TagDto(tagId=471463, tagName=多病多药病人管理)], categoryList=[CategoryDto(categoryId=79, categoryName=护理, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=471463, articleKeyword=多病多药病人管理, articleKeywordNum=6, guiderKeywordId=471463, guiderKeyword=多病多药病人管理, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=解读, guiderLanguage=0, guiderRegion=3, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=2085, appHits=75, showAppHits=0, pcHits=168, showPcHits=2010, likes=0, shares=12, comments=3, approvalStatus=1, publishedTime=Fri Feb 17 20:32:00 CST 2023, publishedTimeString=2023-02-10, pcVisible=1, appVisible=1, editorId=0, editor=dajiong, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=4, createdBy=null, createdName=dajiong, createdTime=Mon Feb 13 17:33:13 CST 2023, updatedBy=2427819, updatedName=梁丽玲, updatedTime=Thu Jan 04 12:43:49 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=安徽省, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=《多病多药病人管理指南》要点解读及拓展.pdf)])
《多病多药病人管理指南》要点解读及拓展.pdf
下载请点击:
评论区 (2)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2117038, encodeId=5ad0211e038d8, content=临床上多重药真的需要干预。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=faa35460034, createdName=ms4000001269442260, createdTime=Wed Mar 01 13:21:30 CST 2023, time=2023-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2115156, encodeId=00752115156af, content=好厉害👍, beContent=null, objectType=guider, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7e252321569, createdName=1224ed23m01(暂无昵称), createdTime=Fri Feb 17 22:20:22 CST 2023, time=2023-02-17, status=1, ipAttribution=北京)]
    2023-03-01 ms4000001269442260

    临床上多重药真的需要干预。

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=2117038, encodeId=5ad0211e038d8, content=临床上多重药真的需要干预。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=faa35460034, createdName=ms4000001269442260, createdTime=Wed Mar 01 13:21:30 CST 2023, time=2023-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2115156, encodeId=00752115156af, content=好厉害👍, beContent=null, objectType=guider, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7e252321569, createdName=1224ed23m01(暂无昵称), createdTime=Fri Feb 17 22:20:22 CST 2023, time=2023-02-17, status=1, ipAttribution=北京)]
    2023-02-17 1224ed23m01(暂无昵称) 来自北京

    好厉害👍

    0